A new study published on medRxiv reveals that diabetes patients using Ozempic face over twice the risk of developing a rare but serio s eye condition compared to those on other diabetes medications. The condition, non-arteritic anterior ischemic optic neuropathy (NAION), can cause sudden and irreversible vision loss. Key Study Findings Researchers analyzed medical records of 16,827 patients in the Boston area over six years. Among the diabetes patients, those prescribed semaglutide experienced NAION at a rate more than four times higher than those who didn’t receive the drug. In the obesity group, 361 people were prescribed the medication, and … Continue reading Study Links Ozempic to 4x Higher Risk of Sudden Blindness in Diabetes Patients—Key Facts About Eye Stroke